EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 -0.2754
March 31, 2026 -0.2807
December 31, 2025 -0.1714
September 30, 2025 -0.1943
June 30, 2025 -0.1853
March 31, 2025 -0.073
December 31, 2024 0.3469
September 30, 2024 -0.112
June 30, 2024 -0.1012
March 31, 2024 -0.1102
December 31, 2023 -0.1394
September 30, 2023 -0.1333
June 30, 2023 -0.1973
March 31, 2023 -0.2146
December 31, 2022 -0.1068
September 30, 2022 -0.0848
June 30, 2022 -0.1704
March 31, 2022 -0.1889
December 31, 2021 -0.1822
September 30, 2021 -0.2201
June 30, 2021 -0.2468
March 31, 2021 -0.6391
December 31, 2020 -0.2584
September 30, 2020 -0.0766
June 30, 2020 -1.326
Date Value
March 31, 2020 -0.2903
December 31, 2019 -1.018
September 30, 2019 -0.3009
June 30, 2019 -0.4233
March 31, 2019 -0.6048
December 31, 2018 -0.4157
September 30, 2018 -1.50
June 30, 2018 -0.48
March 31, 2018 -0.51
December 31, 2017 -0.63
September 30, 2017 -0.57
June 30, 2017 -0.014
March 31, 2017 -0.0052
December 31, 2016 -0.029
September 30, 2016 -0.0198
June 30, 2016 -0.0146
March 31, 2016 -0.0319
December 31, 2015 -0.0677
September 30, 2015 -0.0356
June 30, 2015 -0.0131
March 31, 2015 -0.0068
December 31, 2014 -0.0058
September 30, 2014 -0.0036
June 30, 2014 -0.0095
March 31, 2014 -0.0025

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 0.5324
AngioDynamics, Inc. -0.1689
Alphatec Holdings, Inc. -0.1647
AtriCure, Inc. 0.1832
Baxter International, Inc. 0.2432